PLAU overexpressed in tumor epithelia could increase its binding with the receptor PLAUR, expressed mainly on macrophages, to ultimately influence the aberrant epithelial–immune interactome in HNSCC. The gene discussed is PLAUR; the disease is head and neck squamous cell carcinoma.